Williams Amanda M purchased $16K of ACON
Williams Amanda M purchased 5,857 shares of Aclarion, Inc. (ACON) at $2.73 on 2026-08-17.
How this was made
The 30-second read
Why it matters
The director's purchase modestly increases insider ownership, but the transaction size is too small to influence market perception significantly.
Market read
A minor insider buy; limited relevance for traders beyond monitoring future insider activity.
What to watch
Potential upcoming corporate actions or financing needs not disclosed in the filing.
Background
SEC Form 4 filings disclose insider transactions and are considered primary sources of corporate insider activity.
Ticker impact
Director Amanda Williams purchased 5,857 shares of Aclarion at $2.73 each, increasing her stake to 25,857 shares.
Minimal upward pressure; unlikely to move price materially.
The transaction is a primary Form 4 filing, but the $16K value is trivial for a public company, so any price effect will be marginal.
Market effects
None; the purchase is company‑specific and does not affect the broader sector.
None; limited to Aclarion shareholders.
None; Aclarion is a micro‑cap with minimal global exposure.
Counterpoint
The insider purchase could be a routine portfolio rebalancing rather than a strong endorsement.
Key entities
- CompanyAclarion, Inc.
Micro‑cap biotech company (ticker ACON).
- InsiderAmanda Williams
Director of Aclarion who made the purchase.
